Alector (United States)
company in San Francisco, United States
ALEC Nasdaq
SEC CIK 1653087
Follow Alector (United States)
Weekly email: filings, results
Revenue, last quarter
$162.9M
+4895.9% vs same quarter last year
Net income
$124.6M
+459.4% vs same quarter last year
EPS, diluted
$1.11
+426.5% vs same quarter last year
Operating cash flow
−$24.2M
+25.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $21M | −$143M |
| FY24 | $100.6M | −$119M |
| FY23 | $97.1M | −$130M |
| FY22 | $133.6M | −$133.3M |
| FY21 | $207.1M | −$36.3M |
| FY20 | $21.1M | −$190.2M |
| FY19 | $21.2M | −$105.4M |
| FY18 | $27.5M | −$52.2M |
| FY17 | $2.9M | −$32.5M |
| FY16 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −741.3% | −679.5% |
| FY24 | −144.2% | −118.3% |
| FY23 | −156.3% | −133.9% |
| FY22 | −103.2% | −99.8% |
| FY21 | −18% | −17.5% |
| FY20 | −925.1% | −901.6% |
| FY19 | −539.2% | −496.7% |
| FY18 | −208.3% | −189.9% |
| FY17 | −1137.8% | −1130.9% |
| FY16 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$184.1M |
| FY24 | −$231.2M |
| FY23 | −$186.5M |
| FY22 | −$24.4M |
| FY21 | $295.3M |
| FY20 | −$171.8M |
| FY19 | −$114.6M |
| FY18 | $125.6M |
| FY17 | −$18.6M |
| FY16 | - |
- Alector (United States)
- Healthcare median
Show the numbers
| Year | Alector (United States) | Healthcare median |
|---|---|---|
| FY25 | −679.5% | −30.6% |
| FY24 | −118.3% | −47% |
| FY23 | −133.9% | −58% |
| FY22 | −99.8% | −80.4% |
| FY21 | −17.5% | −71.8% |
| FY20 | −901.6% | −62.2% |
| FY19 | −496.7% | −46.2% |
| FY18 | −189.9% | −49.6% |
| FY17 | −1130.9% | −45.9% |
| FY16 | - | −36% |